{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:59:01Z","timestamp":1789167541392,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00259-022-05679-y","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:04:23Z","timestamp":1642190663000},"page":"2392-2400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Retrospective analysis of PSMA PET\/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment\/outcome in a tertiary cancer referral center and University Medical Center"],"prefix":"10.1007","volume":"49","author":[{"given":"Marceline W.","family":"Piek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten L.","family":"Donswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Paul","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutske","family":"Lodewijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"van Leeuwaarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R.","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen J.","family":"Hartemink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris M. C.","family":"van der Ploeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"5679_CR1","doi-asserted-by":"publisher","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study [published correction appears in JAMA Oncol. 2019; https:\/\/doi.org\/10.1001\/jamaoncol.2019.2996","DOI":"10.1001\/jamaoncol.2019.2996"},{"key":"5679_CR2","doi-asserted-by":"crossref","unstructured":"Boellaard R, O\u2019Doherty MJ, Weber WA, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181\u2013200.","DOI":"10.1007\/s00259-009-1297-4"},{"key":"5679_CR3","doi-asserted-by":"crossref","unstructured":"The Royal College Of Radiologists; Royal College Of Physicians Of London; Royal College Of Physicians And Surgeons Of Glasgow; Royal College Of Physicians Of Edinburgh; British Nuclear Medicine Society; Administration Of Radioactive Substances Advisory Committee. Evidence-based indications for the use of PET-CT in the United Kingdom 2016. Clin Radiol. 2016;71(7):e171-e188.","DOI":"10.1016\/j.crad.2016.05.001"},{"key":"5679_CR4","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/98067945","author":"B Lumbreras","year":"2010","unstructured":"Lumbreras B, Donat L, Hern\u00e1ndez-Aguado I. Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol. 2010. https:\/\/doi.org\/10.1259\/bjr\/98067945.","journal-title":"Br J Radiol"},{"key":"5679_CR5","doi-asserted-by":"crossref","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014 [published correction appears in CA Cancer J Clin. 2014 Sep-Oct;64(5):364]. CA Cancer J Clin. 2014;64(1):9\u201329.","DOI":"10.3322\/caac.21208"},{"key":"5679_CR6","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.178852","author":"J Shoag","year":"2016","unstructured":"Shoag J, Barbieri CE. Clinical variability and molecular heterogeneity in prostate cancer. Asian J Androl. 2016. https:\/\/doi.org\/10.4103\/1008-682X.178852.","journal-title":"Asian J Androl"},{"issue":"4","key":"5679_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/1097-0045(20001201)45:4<350::AID-PROS10>3.0.CO;2-U","volume":"45","author":"RG Lapidus","year":"2000","unstructured":"Lapidus RG, Tiffany CW, Isaacs JT, Slusher BS. Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. Prostate. 2000;45(4):350\u20134.","journal-title":"Prostate"},{"key":"5679_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0096","author":"WP Fendler","year":"2019","unstructured":"Fendler WP, Calais J, Eiber M, et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol. 2019. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0096.","journal-title":"JAMA Oncol"},{"issue":"10231","key":"5679_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208\u201316.","journal-title":"Lancet"},{"issue":"1","key":"5679_CR10","first-page":"81","volume":"3","author":"DA Silver","year":"1997","unstructured":"Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3(1):81\u20135.","journal-title":"Clin Cancer Res"},{"key":"5679_CR11","doi-asserted-by":"crossref","unstructured":"Wang HL, Wang SS, Song WH, et al. Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance. PLoS One. 2015;10(5):e0125924. Published 2015 May 15.","DOI":"10.1371\/journal.pone.0125924"},{"key":"5679_CR12","doi-asserted-by":"publisher","unstructured":"Uijen MJM, Derks YHW, Merkx RIJ, et al. PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports [published online ahead of print, 2021 Jun 12]. Eur J Nucl Med Mol Imaging. 2021; https:\/\/doi.org\/10.1007\/s00259-021-05433-w","DOI":"10.1007\/s00259-021-05433-w"},{"issue":"12","key":"5679_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.humpath.2009.06.003","volume":"40","author":"MC Haffner","year":"2009","unstructured":"Haffner MC, Kronberger IE, Ross JS, et al. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol. 2009;40(12):1754\u201361.","journal-title":"Hum Pathol"},{"key":"5679_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9500-9","author":"M Moore","year":"2017","unstructured":"Moore M, Panjwani S, Mathew R, et al. Well-differentiated thyroid cancer neovasculature expresses prostate-specific membrane antigen-a possible novel therapeutic target. Endocr Pathol. 2017. https:\/\/doi.org\/10.1007\/s12022-017-9500-9.","journal-title":"Endocr Pathol"},{"key":"5679_CR15","doi-asserted-by":"crossref","unstructured":"Bychkov A, Vutrapongwatana U, Tepmongkol S, Keelawat S. PSMA expression by microvasculature of thyroid tumors - potential implications for PSMA theranostics. Sci Rep. 2017;7(1):5202. Published 2017 Jul 12.","DOI":"10.1038\/s41598-017-05481-z"},{"key":"5679_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.06.035","author":"L Lodewijk","year":"2018","unstructured":"Lodewijk L, Willems SM, Dreijerink KMA, et al. The theranostic target prostate-specific membrane antigen is expressed in medullary thyroid cancer. Hum Pathol. 2018. https:\/\/doi.org\/10.1016\/j.humpath.2018.06.035.","journal-title":"Hum Pathol"},{"key":"5679_CR17","doi-asserted-by":"crossref","unstructured":"Heitk\u00f6tter B, Steinestel K, Trautmann M, et al. Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid. Oncotarget. 2018;9(11):9867\u20139874. Published 2018 Jan 4.","DOI":"10.18632\/oncotarget.23984"},{"issue":"10","key":"5679_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00259-015-3065-y","volume":"42","author":"FA Verburg","year":"2015","unstructured":"Verburg FA, Krohn T, Heinzel A, Mottaghy FM, Behrendt FF. First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET\/CT. Eur J Nucl Med Mol Imaging. 2015;42(10):1622\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5679_CR19","doi-asserted-by":"crossref","unstructured":"de Vries LH, Lodewijk L, Braat AJAT, et al. 68Ga-PSMA PET\/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617. EJNMMI Res. 2020;10(1):18. Published 2020 Mar 6.","DOI":"10.1186\/s13550-020-0610-x"},{"issue":"4","key":"5679_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrurol.2016.26","volume":"13","author":"T Maurer","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use of PSMA-PET in prostate cancer management. Nat Rev Urol. 2016;13(4):226\u201335.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"5679_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1053\/j.semnuclmed.2016.07.006","volume":"46","author":"K Bouchelouche","year":"2016","unstructured":"Bouchelouche K, Turkbey B, Choyke PL. PSMA PET and radionuclide therapy in prostate cancer. Semin Nucl Med. 2016;46(6):522\u201335.","journal-title":"Semin Nucl Med"},{"issue":"12","key":"5679_CR22","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2967\/jnumed.116.178673","volume":"57","author":"C Kratochwil","year":"2016","unstructured":"Kratochwil C, Bruchertseifer F, Giesel FL, et al. 225Ac-PSMA-617 for PSMA-targeted \u03b1-radiation therapy of metastatic castration-resistant prostate cancer. J Nucl Med. 2016;57(12):1941\u20134.","journal-title":"J Nucl Med"},{"key":"5679_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06847-9","author":"TJW Klein Nulent","year":"2020","unstructured":"Klein Nulent TJW, Valstar MH, Smit LA, et al. Prostate-specific membrane antigen (PSMA) expression in adenoid cystic carcinoma of the head and neck. BMC Cancer. 2020. https:\/\/doi.org\/10.1186\/s12885-020-06847-9.","journal-title":"BMC Cancer"},{"key":"5679_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12195","author":"AG Wernicke","year":"2014","unstructured":"Wernicke AG, Varma S, Greenwood EA, et al. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. APMIS. 2014. https:\/\/doi.org\/10.1111\/apm.12195.","journal-title":"APMIS"},{"key":"5679_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000002559","author":"R Ciappuccini","year":"2019","unstructured":"Ciappuccini R, Edet-Sanson A, Saguet-Rysanek V, Gauth\u00e9 M, Bardet S. Thyroid Incidentaloma on 18F-fluorocholine PET\/CT and 68Ga-PSMA PET\/CT Revealing a Medullary Thyroid Carcinoma. Clin Nucl Med. 2019. https:\/\/doi.org\/10.1097\/RLU.0000000000002559.","journal-title":"Clin Nucl Med"},{"key":"5679_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-019-00106-8","author":"F Bertagna","year":"2019","unstructured":"Bertagna F, Albano D, Giovanella L, et al. 68Ga-PSMA PET thyroid incidentalomas. Hormones (Athens). 2019. https:\/\/doi.org\/10.1007\/s42000-019-00106-8.","journal-title":"Hormones (Athens)"},{"key":"5679_CR27","doi-asserted-by":"publisher","DOI":"10.1967\/s002449912202","author":"F Gossili","year":"2020","unstructured":"Gossili F, Petersen LJ, Zacho HD. The frequency of thyroid incidental findings and risk of malignancy detected by 68Ga-labeled prostate-specific membrane antigen PET\/CT in prostate cancer. Hell J Nucl Med. 2020. https:\/\/doi.org\/10.1967\/s002449912202.","journal-title":"Hell J Nucl Med"},{"key":"5679_CR28","doi-asserted-by":"publisher","unstructured":"Ceci F, Oprea-Lager DE, Emmett L, et al. E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Eur J Nucl Med Mol Imaging. 2021; https:\/\/doi.org\/10.1007\/s00259-021-05245-y","DOI":"10.1007\/s00259-021-05245-y"},{"key":"5679_CR29","doi-asserted-by":"crossref","unstructured":"Tessler FN, Middleton WD, Grant EG. Thyroid imaging reporting and data system (TI-RADS): a user\u2019s guide [published correction appears in Radiology. 2018 Jun;287(3):1082]. Radiology. 2018;287(1):29\u201336.","DOI":"10.1148\/radiol.2017171240"},{"key":"5679_CR30","doi-asserted-by":"publisher","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016; https:\/\/doi.org\/10.1089\/thy.2015.0020","DOI":"10.1089\/thy.2015.0020"},{"key":"5679_CR31","doi-asserted-by":"crossref","unstructured":"Kaliszewski K, Diakowska D, Wojtczak B, Forkasiewicz Z. Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance\/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology. Cancer Manag Res. 2018;10:2223\u20132229. Published 2018 Jul 23.","DOI":"10.2147\/CMAR.S168409"},{"key":"5679_CR32","doi-asserted-by":"crossref","unstructured":"Treglia G, Bertagna F, Sadeghi R, Verburg FA, Ceriani L, Giovanella L. Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk. Nuklearmedizin. 2013;52(4):130\u2013136.","DOI":"10.3413\/Nukmed-0568-13-03"},{"issue":"1","key":"5679_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1089\/thy.2012.0216","volume":"23","author":"G Treglia","year":"2013","unstructured":"Treglia G, Giovanella L, Bertagna F, Di Franco D, Salvatori M. Prevalence and risk of malignancy of thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron-emission tomography. Thyroid. 2013;23(1):124\u20136.","journal-title":"Thyroid"},{"issue":"3","key":"5679_CR34","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s12020-012-9837-2","volume":"43","author":"F Bertagna","year":"2013","unstructured":"Bertagna F, Treglia G, Piccardo A, et al. F18-FDG-PET\/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine. 2013;43(3):678\u201385.","journal-title":"Endocrine"},{"issue":"11","key":"5679_CR35","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1210\/jc.2012-2390","volume":"97","author":"F Bertagna","year":"2012","unstructured":"Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDG-PET\/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012;97(11):3866\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5679_CR36","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2967\/jnumed.106.039024","volume":"48","author":"D Karantanis","year":"2007","unstructured":"Karantanis D, Bogsrud TV, Wiseman GA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med. 2007;48(6):896\u2013901.","journal-title":"J Nucl Med"},{"issue":"3","key":"5679_CR37","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/01.EHX.0000418503.12452.9a","volume":"35","author":"O Selim Assmaa","year":"2012","unstructured":"Selim Assmaa O, Abd El-Haleem MR, Ibrahim IH. Effect of sodium fluoride on the thyroid gland of growing male albino rats. The Egyptian Journal of Histology. 2012;35(3):470\u201382.","journal-title":"The Egyptian Journal of Histology"},{"issue":"10","key":"5679_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s12149-015-1017-z","volume":"29","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Gorin MA, Hammers HJ, et al. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET\/CT. Ann Nucl Med. 2015;29(10):877\u201382.","journal-title":"Ann Nucl Med"},{"issue":"3","key":"5679_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2967\/jnumed.115.164442","volume":"57","author":"T Pyka","year":"2016","unstructured":"Pyka T, Weirich G, Einspieler I, et al. 68Ga-PSMA-HBED-CC PET for differential diagnosis of suggestive lung lesions in patients with prostate cancer. J Nucl Med. 2016;57(3):367\u201371.","journal-title":"J Nucl Med"},{"issue":"9","key":"5679_CR40","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s00259-015-3066-x","volume":"42","author":"M Sathekge","year":"2015","unstructured":"Sathekge M, Modiselle M, Vorster M, et al. 68Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2015;42(9):1482\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"5679_CR41","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1097\/RLU.0000000000001672","volume":"42","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Schaarschmidt BM, Sawicki LM, et al. Evaluation of practical interpretation Hurdles in 68Ga-PSMA PET\/CT in 55 patients: physiological tracer distribution and incidental tracer uptake. Clin Nucl Med. 2017;42(7):e322\u20137.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"5679_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0972-3919.202248","volume":"32","author":"A Jena","year":"2017","unstructured":"Jena A, Zaidi S, Kashyap V, Jha A, Taneja S. PSMA expression in multinodular thyroid neoplasm on simultaneous Ga-68-PSMA PET\/MRI. Indian J Nucl Med. 2017;32(2):159\u201361. https:\/\/doi.org\/10.4103\/0972-3919.202248.","journal-title":"Indian J Nucl Med"},{"key":"5679_CR43","unstructured":"Richtlijn schildkliercarcinoom inclusief diagnostiek van de nodus. Nederlands Tijdschrift voor Geneeskunde. Available at http:\/\/hdl.handle.net\/1765\/103924. Accessed March 3, 2020."},{"issue":"11","key":"5679_CR44","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s40618-020-01244-2","volume":"43","author":"P Trimboli","year":"2020","unstructured":"Trimboli P, Knappe L, Treglia G, et al. FNA indication according to ACR-TIRADS, EU-TIRADS and K-TIRADS in thyroid incidentalomas at 18F-FDG PET\/CT. J Endocrinol Invest. 2020;43(11):1607\u201312. https:\/\/doi.org\/10.1007\/s40618-020-01244-2.","journal-title":"J Endocrinol Invest"},{"key":"5679_CR45","doi-asserted-by":"publisher","unstructured":"Castellana M, Castellana C, Treglia G, et al. Performance of five ultrasound risk stratification systems in selecting thyroid nodules for FNA. J Clin Endocrinol Metab. 2020;105(5):dgz170. https:\/\/doi.org\/10.1210\/clinem\/dgz170","DOI":"10.1210\/clinem\/dgz170"},{"issue":"5","key":"5679_CR46","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.04","volume":"14","author":"FN Tessler","year":"2017","unstructured":"Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587\u201395. https:\/\/doi.org\/10.1016\/j.jacr.2017.01.04.","journal-title":"J Am Coll Radiol"},{"issue":"7","key":"5679_CR47","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1007\/s00268-017-3919-5","volume":"41","author":"RM Singaporewalla","year":"2017","unstructured":"Singaporewalla RM, Hwee J, Lang TU, Desai V. Clinico-pathological correlation of thyroid nodule ultrasound and cytology using the TIRADS and Bethesda classifications. World J Surg. 2017;41(7):1807\u201311. https:\/\/doi.org\/10.1007\/s00268-017-3919-5.","journal-title":"World J Surg"},{"issue":"5","key":"5679_CR48","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1210\/jc.2008-1724","volume":"94","author":"E Horvath","year":"2009","unstructured":"Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab. 2009;94(5):1748\u201351.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05679-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T01:04:08Z","timestamp":1653267848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-022-05679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5679"],"URL":"https:\/\/doi.org\/10.1007\/s00259-022-05679-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"13 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}